The sluggish kinetics of the oxygen reduction reaction (ORR) and the oxygen evolution reaction (OER) significantly impede the broader implementation of Zn-air batteries (ZABs), underscoring the necessity for advanced high-efficiency materials to catalyze these electrochemical processes. Recent advancements have highlighted the potential of transition metal/carbon nanofiber (TM/CNF) composite materials, synthesized electrospinning technology, due to their expansive surface area, profusion of active sites, and elevated catalytic efficacy. This review comprehensively examines the structural characteristics of TM/CNFs, with a particular emphasis on the pivotal role of electrospinning technology in fabricating diverse structural configurations.
View Article and Find Full Text PDFThe development of low-cost and efficient cathode catalysts is crucial for the advancement of fuel cells, as the oxygen reduction reaction (ORR) on the cathode is constrained by expensive commercial Pt/C catalysts and a significant energy barrier. Metal-organic frameworks (MOFs) are considered excellent precursors for synthesizing carbon nanomaterials due to their simple synthesis, rich structure and composition. MOF-derived carbon nanomaterials (MDCNM) inherit the morphology of their precursors at low dimensional scales, providing abundant edge defects, larger specific surface area, and excellent electron transport paths.
View Article and Find Full Text PDFBackground: The morphological alterations of small pulmonary vessels measured by computed tomography (CT) is increasingly used in evaluation of suspected pulmonary hypertension (PH).
Objective: To investigate the significance alterations of quantitative assessment of small pulmonary vessels on chest CT in distinguishing different types of PH and their severity.
Methods: We retrospectively analyzed a dataset of 120 healthy controls (HCs) and 91 PH patients, including 34 patients with connective tissue diseases-related PH (CTD-PH), 26 patients with idiopathic pulmonary arterial hypertension (iPAH), and 31 patients with chronic obstructive pulmonary disease-related PH (COPD-PH).